262 Longitudinal Assessment of Systemic Lupus Erythematosus Disease Activity: British Isles Lupus Assessment Group 2004, Systemic Lupus Erythematosus Disease Activity Index 2000 or Both?
Chee‐Seng Yee(Unknown), Vernon T. Farewell(University of Cambridge), Caroline Gordon(University of Birmingham), Munther A. Khamashta(The King's College), Ian N Bruce(University of Manchester), David Isenberg(Regenerative Medicine Institute), Neil McHugh(University of Bath), Christopher J Edwards(University Hospital Southampton NHS Foundation Trust), Lee‐Suan Teh(Blackburn College), Mohammed Akil, Yasmeen Ahmad(Betsi Cadwaladr University Health Board), Bridget Griffiths(Freeman Hospital), Athiveeraramapandian Prabu(Sandwell & West Birmingham Hospitals NHS Trust), David D’Cruz(St Thomas' Hospital)
Cited by 3
Related Papers
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
|Annals of the Rheumatic Diseases|2020|2.8k
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
|Annals of the Rheumatic Diseases|2022|1.9k
2022 update
|Radboud Repository (Radboud University)|2010|1.6k
Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for Leukemia
|New England Journal of Medicine|1986|1.5k
Trial of Anifrolumab in Active Systemic Lupus Erythematosus
|New England Journal of Medicine|2019|1.3k